The Mir-423-5p/MMP-2 Axis Regulates the Nerve Growth Factor-Induced Promotion of Chondrosarcoma Metastasis

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2021 Jul 20

PMID 34283074

Citations 8

Authors

Huey-En Tzeng

Syuan-Ling Lin

Louis-Anoop Thadevoos

Chih-Yuan Ko

Ju-Fang Liu

Yu-Wen Huang

Chih-Yang Lin

Yi-Chin Fong

Chih-Hsin Tang

Affiliations

Soon will be listed here.

Abstract

A chondrosarcoma is a common tumor of the soft tissue and bone that has a high propensity to metastasize to distant organs. Nerve growth factor (NGF) is capable of promoting the progression and metastasis of several different types of tumors although the effects of NGF in a chondrosarcoma are not confirmed. Here, we found that the levels of NGF and matrix metalloproteinase-2 (MMP-2) correlated with the tumor stage in patients with a chondrosarcoma. NGF facilitated the MMP-2-dependent cellular migration in human chondrosarcoma JJ012 cells while the overexpression of NGF enhanced the lung metastasis in a mouse model of a chondrosarcoma. NGF promoted the MMP-2 synthesis and cell migration by inhibiting miR-423-5p expression through the FAK and c-Src signaling cascades. NGF appears to be a worthwhile therapeutic target in the treatment of a metastatic chondrosarcoma.

Citing Articles

Nerve growth factor promote VCAM-1-dependent monocyte adhesion and M2 polarization in osteosarcoma microenvironment: Implications for larotrectinib therapy.

Lin S, Yang S, Tsai C, Fong Y, Chen W, Liu J Int J Biol Sci. 2024; 20(11):4114-4127.

PMID: 39247831 PMC: 11379077. DOI: 10.7150/ijbs.95463.

Visfatin-Induced Inhibition of miR-1264 Facilitates PDGF-C Synthesis in Chondrosarcoma Cells and Enhances Endothelial Progenitor Cell Angiogenesis.

Song C, Chang S, Lin C, Tsai C, Yang S, Fong Y Cells. 2022; 11(21).

PMID: 36359873 PMC: 9656973. DOI: 10.3390/cells11213470.

Apelin Promotes Prostate Cancer Metastasis by Downregulating TIMP2 via Increases in miR-106a-5p Expression.

Lin T, Chang S, Khanh P, Trang N, Liu S, Tsai H Cells. 2022; 11(20).

PMID: 36291151 PMC: 9600532. DOI: 10.3390/cells11203285.

Bone tumors effective therapy through functionalized hydrogels: current developments and future expectations.

Shao R, Wang Y, Li L, Dong Y, Zhao J, Liang W Drug Deliv. 2022; 29(1):1631-1647.

PMID: 35612368 PMC: 9154780. DOI: 10.1080/10717544.2022.2075983.

Nerve growth factor promotes lysyl oxidase-dependent chondrosarcoma cell metastasis by suppressing miR-149-5p synthesis.

Tzeng H, Lin S, Thadevoos L, Lien M, Yang W, Ko C Cell Death Dis. 2021; 12(12):1101.

PMID: 34815382 PMC: 8611026. DOI: 10.1038/s41419-021-04392-2.

References

Gelderblom H, Hogendoorn P, Dijkstra S, van Rijswijk C, Krol A, Taminiau A . The clinical approach towards chondrosarcoma. Oncologist. 2008; 13(3):320-9. DOI: 10.1634/theoncologist.2007-0237. View

Su C, Tang C, Chi M, Lin C, Fong Y, Liu Y . Resistin facilitates VEGF-C-associated lymphangiogenesis by inhibiting miR-186 in human chondrosarcoma cells. Biochem Pharmacol. 2018; 154:234-242. DOI: 10.1016/j.bcp.2018.05.001. View

Chen J, Fong Y, Tang C . Novel strategies for the treatment of chondrosarcomas: targeting integrins. Biomed Res Int. 2014; 2013:396839. PMC: 3893802. DOI: 10.1155/2013/396839. View

Jiang J, Bai J, Qin T, Wang Z, Han L . NGF from pancreatic stellate cells induces pancreatic cancer proliferation and invasion by PI3K/AKT/GSK signal pathway. J Cell Mol Med. 2020; 24(10):5901-5910. PMC: 7214160. DOI: 10.1111/jcmm.15265. View

Fan T, Roberts R, Lizardo M . Understanding and Modeling Metastasis Biology to Improve Therapeutic Strategies for Combating Osteosarcoma Progression. Front Oncol. 2020; 10:13. PMC: 7006476. DOI: 10.3389/fonc.2020.00013. View

Chen C, Su C, Huang Y, Tsai C, Fuh L, Tang C . CCN1 induces oncostatin M production in osteoblasts via integrin-dependent signal pathways. PLoS One. 2014; 9(9):e106632. PMC: 4154729. DOI: 10.1371/journal.pone.0106632. View

MacDonald I, Lin C, Kuo S, Su C, Tang C . An update on current and future treatment options for chondrosarcoma. Expert Rev Anticancer Ther. 2019; 19(9):773-786. DOI: 10.1080/14737140.2019.1659731. View

Broderick J, Zamore P . MicroRNA therapeutics. Gene Ther. 2011; 18(12):1104-10. PMC: 3237828. DOI: 10.1038/gt.2011.50. View

Luo T, Zhang S, Zhu L, Zhang F, Li W, Zhao K . A selective c-Met and Trks inhibitor Indo5 suppresses hepatocellular carcinoma growth. J Exp Clin Cancer Res. 2019; 38(1):130. PMC: 6421704. DOI: 10.1186/s13046-019-1104-4. View

10.

Wu T, Lin C, Tsai C, Huang Y, Tang C . Glucose suppresses IL-1β-induced MMP-1 expression through the FAK, MEK, ERK, and AP-1 signaling pathways. Environ Toxicol. 2018; 33(10):1061-1068. DOI: 10.1002/tox.22618. View

11.

Roomi M, Kalinovsky T, Monterrey J, Rath M, Niedzwiecki A . In vitro modulation of MMP-2 and MMP-9 in adult human sarcoma cell lines by cytokines, inducers and inhibitors. Int J Oncol. 2013; 43(6):1787-98. PMC: 3834263. DOI: 10.3892/ijo.2013.2113. View

12.

Puppo M, Valluru M, Clezardin P . MicroRNAs and Their Roles in Breast Cancer Bone Metastasis. Curr Osteoporos Rep. 2021; 19(3):256-263. PMC: 8310490. DOI: 10.1007/s11914-021-00677-9. View

13.

Javadian M, Gharibi T, Shekari N, Abdollahpour-Alitappeh M, Mohammadi A, Hossieni A . The role of microRNAs regulating the expression of matrix metalloproteinases (MMPs) in breast cancer development, progression, and metastasis. J Cell Physiol. 2018; 234(5):5399-5412. DOI: 10.1002/jcp.27445. View

14.

Chen W, Wen Y, Lin S, Yeh H, Jiang K, Chen W . Nerve growth factor interacts with CHRM4 and promotes neuroendocrine differentiation of prostate cancer and castration resistance. Commun Biol. 2021; 4(1):22. PMC: 7782543. DOI: 10.1038/s42003-020-01549-1. View

15.

Steeg P . Targeting metastasis. Nat Rev Cancer. 2016; 16(4):201-18. PMC: 7055530. DOI: 10.1038/nrc.2016.25. View

16.

Higuchi T, Takeuchi A, Munesue S, Yamamoto N, Hayashi K, Kimura H . Anti-tumor effects of a nonsteroidal anti-inflammatory drug zaltoprofen on chondrosarcoma via activating peroxisome proliferator-activated receptor gamma and suppressing matrix metalloproteinase-2 expression. Cancer Med. 2018; 7(5):1944-1954. PMC: 5943440. DOI: 10.1002/cam4.1438. View

17.

Power P, Mak I, Singh S, Popovic S, Gladdy R, Ghert M . ETV5 as a regulator of matrix metalloproteinase 2 in human chondrosarcoma. J Orthop Res. 2012; 31(3):493-501. DOI: 10.1002/jor.22227. View

18.

Wojciechowska A, Braniewska A, Kozar-Kaminska K . MicroRNA in cardiovascular biology and disease. Adv Clin Exp Med. 2017; 26(5):865-874. DOI: 10.17219/acem/62915. View

19.

Leddy L, Holmes R . Chondrosarcoma of bone. Cancer Treat Res. 2014; 162:117-30. DOI: 10.1007/978-3-319-07323-1_6. View

20.

Zhu X, Wang K, Chen Y . Ophiopogonin D suppresses TGF-β1-mediated metastatic behavior of MDA-MB-231 breast carcinoma cells via regulating ITGB1/FAK/Src/AKT/β-catenin/MMP-9 signaling axis. Toxicol In Vitro. 2020; 69:104973. DOI: 10.1016/j.tiv.2020.104973. View